NovaTarg Therapeutics Inc - Company Review
NovaTarg Therapeutics Inc - Company ReviewSummary
NovaTarg Therapeutics Inc (NovaTarg) is a healthcare products company that manufactures drug products. The company discovers and develops new drugs for metabolic diseases, cancer and viral infections. It develops AMP-activated kinase activator compounds that enter cells through specific cell membrane transporters and regulate energy use and cell growth in the target cells. NovaTarg’s AMPK activator compounds have the potential to treat a range of liver diseases such as hepatocellular carcinoma, hepatitis C, fatty liver disease, and type 2 diabetes. The LKB1-AMPK pathway plays a crucial role in tumor suppression as it inhibits both cell proliferation and protein synthesis. NovaTarg is headquartered in Research Triangle Park, North Carolina, the US.
This comprehensive company report of NovaTarg Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.